1. Effects of daily consumption of the probiotic Bifidobacterium animalis subsp. lactis CECT 8145 on anthropometric adiposity biomarkers in abdominally obese subjects: a randomized controlled trial
- Author
-
Lorena Calderón-Pérez, Yolanda Ortega, Francisco Martín-Luján, Judit Companys, Patricia Martorell, Anna Pedret, Laura Pla-Pagà, Rosa Solà, Ana Moragas, Lluís Arola, Elisabet Llauradó, Francisco M. Codoñer, Antoni Caimari, Salvador Genovés, Rosa M. Valls, Daniel Ramón, Empar Chenoll, and Montse Giralt
- Subjects
Adult ,Male ,medicine.medical_specialty ,Waist ,Endocrinology, Diabetes and Metabolism ,Medicine (miscellaneous) ,030209 endocrinology & metabolism ,Brief Communication ,Placebo ,Gastroenterology ,law.invention ,03 medical and health sciences ,Probiotic ,0302 clinical medicine ,Bifidobacterium animalis ,law ,Internal medicine ,Humans ,Medicine ,Ingestion ,Obesity ,030212 general & internal medicine ,Adiposity ,Nutrition and Dietetics ,biology ,business.industry ,Probiotics ,Akkermansia ,biology.organism_classification ,Blood pressure ,Risk factors ,Obesity, Abdominal ,Female ,Waist Circumference ,business ,Body mass index - Abstract
Background The effects of probiotic Bifidobacterium animalis subsp. lactis CECT 8145 (Ba8145) and those of its heat-killed form (h-k Ba8145) on human anthropometric adiposity biomarkers are unknown. Objective To assess the effect of Ba8145 and h-k Ba8145 ingestion on anthropometric adiposity biomarkers. Design Randomized, parallel, double-blind, placebo-controlled trial with abdominally obese individuals. Participants (n = 135) consumed 1 capsule/day containing 1010 colony forming unit (CFU) of Ba8145, 1010 CFU of h-k Ba8145, or placebo (maltodextrin) for 3 months. Results Ba8145 ingestion decreased waist circumference, waist circumference/height ratio, and Conicity index (P
- Published
- 2018
- Full Text
- View/download PDF